Targeted Next-Generation Sequencing of Liquid Biopsy Samples from Patients with NSCLC

Liquid biopsy tests have become an integral part of the molecular diagnosis of patients with non-small cell lung cancer (NSCLC). We describe a new test panel that uses very low input (20 ng) of cell-free nucleic acids extracted from human plasma, which is designed to yield results in less than 72 h....

Descripción completa

Detalles Bibliográficos
Autores principales: Mellert, Hestia, Reese, Jordan, Jackson, Leisa, Maxwell, Victoria, Tschida, Chérie, Pestano, Gary A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912015/
https://www.ncbi.nlm.nih.gov/pubmed/33494470
http://dx.doi.org/10.3390/diagnostics11020155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912015/
https://www.ncbi.nlm.nih.gov/pubmed/33494470
http://dx.doi.org/10.3390/diagnostics11020155

Ejemplares similares